Medicare

Teva Delivers Second Consecutive Year of Growth; Announces Strong Financial Results in Fourth Quarter and Full Year 2024, Led by Generics Performance and Innovative Portfolio Growth

Study Published in Journal of Cardiothoracic and Vascular Anesthesia Finds Accuryn Monitoring System Detects Acute Kidney Injury (AKI) in Cardiac Surgery Patients 33 Hours Earlier than Standard Serum Creatine Criteria

Helius Medical Technologies, Inc. Announces First Clinical Evidence of Positive Long-term Therapeutic Effects of PoNS Therapy® on Gait Deficit Improvement in Multiple Sclerosis from the PoNS® Therapeutic Experience Program Study

Top 100 Healthcare IT Consultant Project Areas in Highest Demand: Leading Advisory Firms Driving the Future of Healthcare Innovation

Accenture, Deloitte, PwC, Huron Consulting Group, Nordic Consulting Partners, Chartis Group, McKinsey & Company, Optum, Clearwater, Cognizant, Salesforce, and Vizient...

Bausch Health Statement on Selection of XIFAXAN(R) (rifaximin) for Inflation Reduction Act’s Medicare Negotiation Program

LAVAL, QC / ACCESS Newswire / January 17, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) and its gastroenterology (GI) business,...

error: Content is protected !!